NCT05591742View on ClinicalTrials.gov

Bacterial Composition and Recurrent Cystitis in Postmenopausal Women After Treatment With Lactobacilli.

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2025

Conditions
Cystitis RecurrentLactobacillus Infection
Interventions
DIETARY_SUPPLEMENT

FEMIDUR®

"Femidur® consist of 2 vaginal lactobacillis; Lactobacillus rhamnosus GR-1® and Lactobacillus reuteri RC-14®. One tablet a day.~Placebo Z Cap V-3 Pla; mainly maltodextrin"

OTHER

Placebo Z Cap V-3 Pla

Consist mainly of maltodextrin. One tablet a day.

Trial Locations (1)

9000

RECRUITING

AalborgH, Aalborg

All Listed Sponsors
collaborator

Aalborg University

OTHER

lead

Aalborg University Hospital

OTHER